The Anew journal · November 15, 2026

How Many Kybella Treatments Will You Need? How Providers Plan a Series

Kybella's label allows up to six sessions at least a month apart. Learn how providers decide whether to continue, what the trials showed, how to plan between sessions, and when to call.

Kybella's FDA label allows up to six treatment sessions for fat under the chin, spaced at least one month apart, but there is no set number for everyone: your provider decides at each visit whether another session makes sense, based on how much fat remains, how your skin and neck look, and how you tolerated the last treatment.

How many Kybella sessions does the label allow?

Kybella (deoxycholic acid) is a prescription injection approved by the FDA to improve the appearance of moderate to severe convexity or fullness associated with fat under the chin (submental fat) in adults. The label does not approve it for fat elsewhere on the body. Its prescribing information states that up to six treatments may be given, at intervals of no less than one month.

The amount used at each session is not a fixed vial count. The label describes an area-adjusted dose: small injections spaced about 1 centimeter apart across the marked treatment area, up to a stated maximum per session. A smaller treatment area generally means fewer injection points. The label also says the number of injections and the number of treatments should be tailored to each person's fat distribution and treatment goals, so your treatment plan is set and revised visit by visit.

The American Society of Plastic Surgeons (ASPS) says most patients have at least two treatments spaced four to six weeks apart, and up to six treatments may be given to the area under the chin.

What happens at each Kybella session?

The label describes the same basic steps for every session. Before injecting, the provider feels the area under the chin to confirm there is still enough fat in the layer between the skin and the underlying neck muscle (the platysma) to treat. The treatment area is outlined with a surgical pen and marked with a 1-centimeter grid, and Kybella injections are placed into the fat at the marked points. Ice or cold packs and topical or injected numbing medicine may be used for comfort.

The label tells providers to avoid a zone along the lower jawline to protect the marginal mandibular nerve, a facial nerve branch whose injury can cause an uneven smile, and to keep injections away from salivary glands, lymph nodes and muscle. Because earlier surgery or cosmetic treatment can change these landmarks, mention any past procedures under the chin at your first visit and if anything new has happened since your last one.

What did the clinical trials show about the number of sessions?

The two main trials described in the Kybella label enrolled adults aged 19 to 65 with moderate or severe fullness under the chin and without excessive skin laxity. Participants could receive up to six treatments at least one month apart, and results were assessed 12 weeks after the final treatment.

In those trials, 59% of participants received all six treatments, so a substantial share stopped earlier. The average amount injected at the sixth session was lower than the average at the first. These are group averages from a research setting; they do not predict how many sessions you will need or how you will respond.

The trials measured Kybella results 12 weeks after the last treatment, using both a clinician rating and the participant's own rating. An improvement of at least one grade on both ratings was seen in 70.0% and 66.5% of Kybella-treated participants in the two trials, compared with 18.6% and 22.2% of those given placebo. An improvement of at least two grades on both ratings was less common: 13.4% and 18.6% with Kybella, compared with less than 0.1% and 3.0% with placebo. In a subset who had MRI scans, 43% of Kybella-treated participants had at least a 10% reduction in fat volume under the chin, compared with 5% on placebo.

How does a provider decide whether to continue?

Each visit is a new assessment. ASPS notes that fat reduction is typically visible six to eight weeks after a treatment, which is one reason sessions are spaced weeks apart: it gives time to see what changed. Before another session, a provider may consider:

  • How much fat remains. As submental fullness decreases, the area that needs treatment may shrink, or treatment may no longer be needed.
  • Skin and neck features. The label asks providers to weigh the risks for people with excessive skin laxity, prominent neck bands or other features for which reducing fat could give an unwanted look. ASPS notes that people with loose skin or poor tone may not be suitable candidates.
  • How you tolerated the last session. Swelling, numbness or firmness should be reviewed, and symptoms such as trouble swallowing or an uneven smile need evaluation before any further treatment.
  • Your goals. Some people decide they are satisfied before reaching six sessions. Others may find that a different approach suits their anatomy better.

The label also tells providers to consider holding further treatments if hair loss develops in the treated area until it resolves, and to stop Kybella if skin sores, tissue damage, lumps or masses, or infection develop at the injection site. It does not describe more than six sessions. If additional treatment is suggested beyond that, ask how the recommendation fits the labeling and what the alternatives are.

Series length also differs from person to person. Starting fullness, the size of the treatment area and how your tissue responds all vary. Earlier surgery or cosmetic treatment under the chin can matter too: the label advises caution because changes in anatomy or scar tissue may affect both safe administration and the result. Fullness under the chin can also have causes other than fat, and the label tells providers to screen for conditions such as an enlarged thyroid or swollen lymph nodes before starting.

What side effects can come with multiple sessions?

Side effects can occur after any session, so a series means planning for more than one recovery period. In the pooled trials, the most common reactions at the injection site in Kybella-treated participants were swelling (87%), bruising (72%), pain (70%), numbness (66%), redness (27%) and areas of hardness (23%). Some lasted longer than 30 days, most often numbness, which persisted that long in 42% of Kybella-treated participants.

The label also lists serious side effects. Nerve injury causing an uneven smile or facial muscle weakness was reported in 4% of Kybella-treated trial participants, and difficulty swallowing in 2%; in the trials these resolved without additional treatment, but recovery ranged from days to months. Since approval, reports have included open sores, tissue damage, hair loss, scarring, infection, and lumps or masses that may not go away and may need medical treatment. Damage to an artery or vein can occur if the medicine is injected into a blood vessel by mistake. These are not all the possible side effects, and any of them can affect whether further sessions are appropriate.

How should you plan between sessions?

The label sets the minimum period between treatments at one month, so a full series can span several months. Cleveland Clinic advises keeping follow-up appointments and calling your care team if you cannot make one.

Tell your provider before each session about any new medicines, especially those that affect bleeding, and any new health conditions. The patient information asks you to share all of your medical conditions, including trouble swallowing, bleeding problems, conditions in or near the neck, past or planned surgery or cosmetic treatment on the face, neck or chin, and whether you are pregnant, breastfeeding or planning either; it states that it is not known whether Kybella can harm an unborn baby or passes into breast milk. Avoid use of KYBELLA in patients with a current or prior history of dysphagia because KYBELLA use may exacerbate the condition. The label advises caution in people with bleeding problems or who take blood thinners or antiplatelet medicines, and lists infection in the treatment area as a reason not to treat.

When should you call your provider or get urgent care?

Contact your treating clinician immediately for new or worsening difficulty swallowing, even if mild. Seek emergency care if you cannot swallow saliva, have trouble breathing or feel your throat closing. Report facial weakness, an uneven smile or infection signs promptly. Let your provider know promptly about firm lumps or swelling that is not improving.

Get emergency care for trouble breathing or for swelling of the face, lips, tongue or throat, which can signal a serious allergic reaction. Follow the written aftercare instructions from your treating provider.

Questions to ask about a Kybella series

  • Based on my exam, how many sessions might be considered, and what would tell us to stop?
  • How will you measure change between sessions?
  • Does my skin laxity or neck anatomy affect whether Kybella suits me?
  • How much swelling should I plan for after each session?
  • Which symptoms should make me call before my next appointment?
  • What are my options if I do not see the change I want?

Read what Kybella is and what it is approved for, prepare with the consultation checklist, or use the contact page to ask whether Kybella is offered at your location. Individual results vary.

Independent sources

Learn about Facial Aesthetics at Anew Laser MD


General educational information is not a diagnosis or treatment recommendation. Consult a qualified clinician about your individual circumstances.